## Statistical Validation Report

**Validation Date:** 2026-01-02 21:35
**Agent:** rq_stats v5.0
**Status:** ⚠️ CONDITIONAL
**Overall Score:** 9.0 / 10.0

---

### Rubric Scoring Summary

| Category | Score | Max | Status |
|----------|-------|-----|--------|
| Statistical Appropriateness | 2.8 | 3.0 | ⚠️ |
| Tool Availability | 1.7 | 2.0 | ⚠️ |
| Parameter Specification | 1.9 | 2.0 | ⚠️ |
| Validation Procedures | 1.8 | 2.0 | ⚠️ |
| Devil's Advocate Analysis | 0.8 | 1.0 | ⚠️ |
| **TOTAL** | **9.0** | **10.0** | **⚠️ CONDITIONAL** |

---

### Detailed Rubric Evaluation

#### Statistical Appropriateness (2.8 / 3.0)

**Criteria Checklist:**
- [x] Method matches RQ (classification analysis appropriate for identifying false negatives)
- [x] Model structure appropriate for data (cross-sectional, simple descriptive analysis)
- [x] Analysis simplest method that answers RQ (avoids unnecessary complexity)
- [x] Assumptions checkable with available data (N=100 sufficient for basic tests)
- [ ] Methodological soundness (minor concerns about threshold justification)

**Assessment:**
The proposed cross-sectional classification approach is highly appropriate for identifying "false negative" cases where RAVLT and REMEMVR assessments disagree. The 2x2 classification matrix using standardized z-scores enables fair comparison between different measurement scales. The analysis maintains appropriate simplicity for a clinical utility study focused on descriptive characterization rather than causal inference.

**Strengths:**
- Method directly addresses the research question about discordant cases
- Z-score standardization enables valid cross-test comparison
- Clinical metrics (sensitivity/specificity) appropriate for diagnostic utility assessment
- Sample size adequate for descriptive analysis and basic group comparisons

**Concerns / Gaps:**
- Classification thresholds (-1.0 for RAVLT, -0.5 for REMEMVR) appear arbitrary without literature justification
- No mention of assumption checking for t-tests (normality, equal variances)
- Small expected cell sizes (6-10 cases) may limit statistical power for group comparisons

**Score Justification:**
Strong methodological approach with minor concerns about threshold justification. The method is appropriate, well-matched to the RQ, and maintains appropriate complexity for the clinical utility focus. Threshold selection needs better justification but doesn't undermine the overall approach.

#### Tool Availability (1.7 / 2.0)

**Source:** `docs/v4/tools_inventory.md`

**Analysis Pipeline Steps:**

| Step | Tool Function | Status | Notes |
|------|---------------|--------|-------|
| Step 1: Data Loading | Standard pandas/numpy functions | ✅ Available | Basic data manipulation available |
| Step 2: Z-score Standardization | scipy.stats.zscore | ✅ Available | Standard statistical functions |
| Step 3: Classification Logic | Basic pandas operations | ✅ Available | Boolean indexing and filtering |
| Step 4: Group Comparisons | scipy.stats.ttest_ind, chi2_contingency | ✅ Available | Standard statistical tests |
| Step 5: Dual P-values | tools.analysis_lmm.compute_contrasts_pairwise | ✅ Available | Decision D068 compliance |
| Step 6: Clinical Metrics | tools.clinical.compute_sensitivity_specificity | ⚠️ Missing | Needs implementation |
| Step 7: Contingency Tables | tools.data.create_classification_matrix | ⚠️ Missing | Needs implementation |
| Step 8: Plotting | tools.plotting.plot_scatter_with_quadrants | ✅ Available | Scatter plot functionality |

**Tool Reuse Rate:** 6/8 tools (75%)

**Missing Tools:**
1. **Tool Name:** `tools.clinical.compute_sensitivity_specificity`
   - **Required For:** Step 6 - Calculate diagnostic performance metrics
   - **Priority:** Medium (can be computed manually but tool standardizes output)
   - **Specifications:** Input: 2x2 classification matrix, Output: sensitivity, specificity, PPV, NPV with 95% CIs
   - **Recommendation:** Implement before rq_analysis phase

2. **Tool Name:** `tools.data.create_classification_matrix`
   - **Required For:** Step 3 - Generate labeled 2x2 contingency table
   - **Priority:** Low (pandas.crosstab available but tool provides standardized format)
   - **Specifications:** Input: two classification vectors, Output: formatted contingency table with labels
   - **Recommendation:** Implement during rq_analysis if needed

**Tool Availability Assessment:**
⚠️ Acceptable (75% tool reuse): Most required tools exist, 2 missing tools need implementation

#### Parameter Specification (1.9 / 2.0)

**Criteria Checklist:**
- [x] Parameters clearly specified (classification thresholds, correction methods)
- [ ] Parameters appropriately justified (thresholds appear arbitrary)
- [x] Validation thresholds mentioned (dual p-value reporting with Bonferroni)

**Assessment:**
Classification thresholds are explicitly stated (RAVLT z < -1.0, REMEMVR z > -0.5) and Decision D068 dual p-value reporting is correctly specified. However, the choice of these specific threshold values lacks literature justification. The -1.0 threshold corresponds to 16th percentile (mild impairment) which is reasonable, but the asymmetric -0.5 threshold for REMEMVR is not well-justified.

**Strengths:**
- Clear threshold specification for both measures (RAVLT z < -1.0, REMEMVR z > -0.5)
- Correct implementation of Decision D068 (dual p-value reporting with Bonferroni)
- Sample size constraints acknowledged (N=100)
- Expected effect sizes mentioned (6-10% false negative rate)

**Concerns / Gaps:**
- Asymmetric thresholds (-1.0 vs -0.5) lack theoretical justification
- No sensitivity analysis planned for threshold variation
- No citation of clinical literature supporting threshold choices

**Score Justification:**
Well-specified parameters with minor concerns about threshold justification. The analysis is implementable as specified but would benefit from literature support for threshold selection or sensitivity analysis across multiple threshold combinations.

#### Validation Procedures (1.8 / 2.0)

**Criteria Checklist:**
- [x] Basic validation mentioned (dual p-value reporting)
- [ ] Comprehensive assumption checking (t-test normality, equal variances not specified)
- [x] Remedial actions implied (chi-square for categorical data)

**Assessment:**
The concept specifies Decision D068 dual p-value reporting for multiple comparisons, which is appropriate. The analysis plans both t-tests and chi-square tests, suggesting awareness of appropriate test selection based on data type. However, explicit assumption checking for t-tests is not mentioned.

**Strengths:**
- Correct specification of multiple testing correction (Bonferroni per Decision D068)
- Appropriate use of different statistical tests based on data type (t-test vs chi-square)
- Sample size considerations acknowledged for group comparisons

**Concerns:**
- No explicit mention of t-test assumption checking (normality, equal variances)
- No validation procedures for the classification thresholds themselves
- No power analysis for detecting group differences with small false negative sample (6-10 cases)

**Recommendations:**
- Specify assumption validation via Shapiro-Wilk test (normality) and Levene's test (equal variances)
- Plan non-parametric alternatives if assumptions violated (Mann-Whitney U, Fisher's exact test)
- Acknowledge power limitations due to small expected false negative group

**Score Justification:**
Adequate validation procedures with Decision D068 compliance, but missing explicit assumption checking protocols for parametric tests. The approach is sound but would benefit from more comprehensive validation planning.

---

### Tool Availability Validation

**Source:** `docs/v4/tools_inventory.md`

**Analysis Pipeline Steps:**

| Step | Tool Function | Status | Notes |
|------|---------------|--------|-------|
| Step 1: Extract Data | pandas.read_csv, standard data loading | ✅ Available | Basic data manipulation |
| Step 2: Standardize Scores | scipy.stats.zscore | ✅ Available | Z-score transformation |
| Step 3: Create Classification | Basic pandas boolean operations | ✅ Available | Logical indexing |
| Step 4: Group Demographics | Standard descriptive statistics | ✅ Available | Mean, std, count functions |
| Step 5: Statistical Tests | scipy.stats.ttest_ind, chi2_contingency | ✅ Available | Standard hypothesis tests |
| Step 6: Dual P-values | tools.analysis_lmm.compute_contrasts_pairwise | ✅ Available | Decision D068 implementation |
| Step 7: Clinical Metrics | tools.clinical.compute_sensitivity_specificity | ⚠️ Missing | Needs implementation |
| Step 8: Visualization | tools.plotting functions | ✅ Available | Scatter and comparison plots |

**Tool Reuse Rate:** 6/8 tools (75%)

**Missing Tools (If Any):**
1. **Tool Name:** `tools.clinical.compute_sensitivity_specificity`
   - **Required For:** Step 6 - Compute diagnostic performance metrics
   - **Priority:** Medium
   - **Specifications:** Input 2x2 matrix, output sensitivity/specificity with 95% CI
   - **Recommendation:** Implement before rq_analysis phase

2. **Tool Name:** `tools.data.create_classification_matrix`
   - **Required For:** Step 3 - Generate labeled contingency table
   - **Priority:** Low
   - **Specifications:** Input two classification vectors, output formatted table
   - **Recommendation:** Use pandas.crosstab as alternative

**Tool Availability Assessment:**
⚠️ Acceptable (75% tool reuse): Core statistical and data manipulation tools available, 2 specialized tools missing but implementable

---

### Validation Procedures Checklists

#### Basic Statistical Tests Validation

| Assumption | Test | Threshold | Assessment |
|------------|------|-----------|------------|
| T-test Normality | Shapiro-Wilk | p>0.05 | ⚠️ Not specified in concept |
| Equal Variances | Levene's test | p>0.05 | ⚠️ Not specified in concept |
| Chi-square Cell Size | Expected cell count | ≥5 per cell | ⚠️ Risk with 6-10 false negatives |
| Sample Size | Group comparison power | N≥30 per group | ❌ False negative group ~6-10 |

**Statistical Tests Validation Assessment:**
The concept appropriately selects different test types (t-test for continuous, chi-square for categorical) but lacks explicit assumption checking. Small expected false negative group (6-10 cases) may violate minimum sample size assumptions for parametric tests.

**Concerns:**
- No mention of normality testing before t-tests
- No plan for small cell size handling in chi-square tests
- Power analysis missing for small group comparisons

**Recommendations:**
- Add explicit assumption checking with remedial actions
- Consider non-parametric alternatives for small groups
- Report effect sizes and confidence intervals regardless of significance

---

#### Decision Compliance Validation

| Decision | Requirement | Implementation | Compliance |
|----------|-------------|----------------|------------|
| D068: Dual Reporting | Report both uncorrected and Bonferroni p-values | Step 5: Dual p-value output mentioned | ✅ FULLY COMPLIANT |

**Decision Compliance Assessment:**
Decision D068 (dual p-value reporting) is correctly specified. Concept mentions reporting both uncorrected and Bonferroni-corrected p-values for multiple comparisons.

---

### Statistical Criticisms & Rebuttals

**Analysis Approach:**
- **Focus:** Standard regression methods validation (WebSearch skipped per instructions)
- **Scope:** Commission errors (questionable assumptions), omission errors (missing considerations), alternative approaches, known pitfalls
- **Grounding:** Methodological knowledge and statistical best practices

---

#### Commission Errors (Questionable Statistical Assumptions/Claims)

**1. Arbitrary Classification Thresholds**
- **Location:** 1_concept.md - Section 6: Analysis Approach, Step 2
- **Claim Made:** "Low RAVLT: z-score < -1.0 (16th percentile), Normal REMEMVR: z-score > -0.5 (31st percentile)"
- **Statistical Criticism:** Asymmetric thresholds appear arbitrary without literature justification. Why -1.0 for RAVLT but -0.5 for REMEMVR? Different severity criteria suggest the comparison isn't equivalent.
- **Methodological Counterevidence:** Clinical assessment guidelines typically use consistent severity thresholds across measures (e.g., -1.5 SD for mild impairment)
- **Strength:** MODERATE
- **Suggested Rebuttal:** "Provide literature justification for threshold selection or use symmetric thresholds (e.g., both at -1.0 SD). Consider sensitivity analysis across multiple threshold combinations to demonstrate robustness."

---

#### Omission Errors (Missing Statistical Considerations)

**1. No Assumption Checking for T-tests**
- **Missing Content:** No mention of normality or equal variance testing for group comparisons
- **Why It Matters:** With N=100 and potentially 6-10 cases in false negative group, assumption violations could affect validity of parametric tests
- **Supporting Literature:** Standard statistical practice requires assumption validation, especially with small/unequal group sizes
- **Potential Reviewer Question:** "How will you verify normality and equal variance assumptions for parametric tests with the small false negative group?"
- **Strength:** MODERATE
- **Suggested Addition:** "Add to Section 6: specify assumption checking via Shapiro-Wilk test (normality) and Levene's test (equal variances). Specify non-parametric alternatives (Mann-Whitney U, Fisher's exact) if assumptions violated."

**2. No Power Analysis for Small Groups**
- **Missing Content:** No power analysis for detecting group differences with small false negative sample
- **Why It Matters:** 6-10 false negatives vs remaining 90-94 participants creates severe power imbalance for detecting meaningful differences
- **Supporting Literature:** Post-hoc comparisons with small, unequal groups are typically underpowered
- **Potential Reviewer Question:** "What is the statistical power to detect meaningful demographic differences with such a small false negative group?"
- **Strength:** CRITICAL
- **Suggested Addition:** "Add to Section 6: acknowledge power limitations due to small false negative group. Emphasize effect size reporting and confidence intervals rather than solely significance testing. Consider descriptive characterization approach."

---

#### Alternative Statistical Approaches (Not Considered)

**1. Continuous Discrepancy Score Analysis**
- **Alternative Method:** Continuous discrepancy analysis (REMEMVR z-score minus RAVLT z-score) rather than binary classification
- **How It Applies:** Preserves information lost in dichotomization, allows correlation/regression analysis of discrepancy with demographics
- **Key Citation:** Methodological literature generally favors continuous measures over artificial dichotomization for increased statistical power
- **Why Concept.md Should Address It:** Binary classification loses statistical power and may create arbitrary boundaries between "normal" and "impaired"
- **Strength:** MODERATE
- **Suggested Acknowledgment:** "Add brief discussion acknowledging continuous alternative approach. Justify binary classification for clinical interpretability despite reduced statistical power."

---

#### Known Statistical Pitfalls (Unaddressed)

**1. Multiple Testing Inflation**
- **Pitfall Description:** Multiple demographic comparisons (age, education, NART, VR experience) planned without clear family-wise correction scope
- **How It Could Affect Results:** Inflated Type I error rate across multiple demographic tests could lead to false positive findings
- **Literature Evidence:** Multiple comparisons require family-wise error rate control to maintain nominal alpha level
- **Why Relevant to This RQ:** Concept mentions several demographic variables but unclear if Bonferroni correction applies to all comparisons or just primary tests
- **Strength:** MODERATE
- **Suggested Mitigation:** "Clarify in Section 6: specify exact scope of multiple testing correction. Apply family-wise correction across ALL demographic comparisons or justify selection of primary vs exploratory comparisons."

---

#### Scoring Summary

**Total Concerns Identified:**
- Commission Errors: 1 (1 MODERATE)
- Omission Errors: 2 (1 CRITICAL, 1 MODERATE)
- Alternative Approaches: 1 (1 MODERATE)
- Known Pitfalls: 1 (1 MODERATE)

**Overall Devil's Advocate Assessment:**
The concept demonstrates reasonable statistical planning but has notable gaps in assumption checking and power considerations. The arbitrary threshold selection and lack of power analysis for small group comparisons are the most significant concerns. The approach is implementable but would benefit from more rigorous statistical foundation and explicit acknowledgment of limitations.

---

### Recommendations

#### Required Changes (Must Address for Approval)

1. **Add Assumption Checking Procedures**
   - **Location:** 1_concept.md - Section 6: Analysis Approach, Step 5
   - **Issue:** No mention of assumption validation for parametric tests (t-tests) with potentially small false negative group
   - **Fix:** Add explicit text: "Before conducting t-tests, validate normality (Shapiro-Wilk test, p>0.05) and equal variances (Levene's test, p>0.05). If assumptions violated, use Mann-Whitney U test for continuous variables and Fisher's exact test for small cell counts in contingency tables."
   - **Rationale:** Essential for statistical validity with small, potentially unequal groups (Category 4: Validation Procedures)

2. **Acknowledge Power Limitations**
   - **Location:** 1_concept.md - Section 6: Analysis Approach, Step 5 or new Step 6.5
   - **Issue:** No acknowledgment of limited power to detect group differences with 6-10 false negatives vs 90-94 other participants
   - **Fix:** Add text: "Acknowledge limited statistical power for group comparisons due to small expected false negative sample (6-10 cases). Emphasize effect size estimation and confidence intervals. Frame analysis as descriptive characterization rather than hypothesis testing."
   - **Rationale:** Critical for managing expectations and interpreting results appropriately (Category 5: Devil's Advocate Analysis - CRITICAL concern)

#### Suggested Improvements (Optional but Recommended)

1. **Justify Classification Thresholds**
   - **Location:** 1_concept.md - Section 6: Analysis Approach, Step 2
   - **Current:** "Low RAVLT: z-score < -1.0 (16th percentile), Normal REMEMVR: z-score > -0.5 (31st percentile)"
   - **Suggested:** Add literature citation or rationale for asymmetric thresholds, or consider symmetric thresholds (both at -1.0 SD) for equivalent severity criteria
   - **Benefit:** Strengthens methodological foundation and addresses potential reviewer criticism about arbitrary threshold selection

2. **Clarify Multiple Testing Scope**
   - **Location:** 1_concept.md - Section 6: Analysis Approach, Step 5
   - **Current:** "Report BOTH uncorrected AND corrected p-values (Decision D068)"
   - **Suggested:** Specify exactly which comparisons are included in family-wise correction (all demographic variables vs primary subset)
   - **Benefit:** Eliminates ambiguity about correction scope and ensures appropriate Type I error control

3. **Consider Sensitivity Analysis**
   - **Location:** 1_concept.md - Section 6: Analysis Approach, new subsection
   - **Current:** Fixed thresholds only
   - **Suggested:** "Consider sensitivity analysis testing multiple threshold combinations (e.g., -1.5/-1.0, -1.0/-0.5, -0.5/-0.5) to demonstrate robustness of false negative identification"
   - **Benefit:** Addresses arbitrary threshold concern and strengthens clinical interpretability

#### Missing Tools (For Master/User Implementation)

1. **Tool Name:** `tools.clinical.compute_sensitivity_specificity`
   - **Required For:** Step 6 - Clinical performance metrics calculation
   - **Priority:** Medium
   - **Specifications:** Input 2x2 classification matrix (true positive, false positive, false negative, true negative), output sensitivity, specificity, PPV, NPV with 95% confidence intervals using Wilson score method
   - **Recommendation:** Implement before rq_analysis phase

2. **Tool Name:** `tools.data.create_classification_matrix`
   - **Required For:** Step 3 - Generate labeled contingency table
   - **Priority:** Low
   - **Specifications:** Input two classification vectors (e.g., RAVLT_low, REMEMVR_normal), output formatted DataFrame with row/column labels and cell counts
   - **Recommendation:** Can use pandas.crosstab as alternative, tool implementation optional

---

### Validation Metadata

- **Agent Version:** rq_stats v5.0
- **Rubric Version:** 10-point system (v5.0)
- **Validation Date:** 2026-01-02 21:35
- **Tools Inventory Source:** docs/v4/tools_inventory.md
- **Total Tools Validated:** 8
- **Tool Reuse Rate:** 75% (6/8 tools available)
- **Validation Duration:** ~25 minutes
- **Context Dump:** "9.0/10 CONDITIONAL. Category 1: 2.8/3 (appropriate method, minor threshold concerns). Category 2: 1.7/2 (75% tool reuse). Category 3: 1.9/2 (clear parameters, arbitrary thresholds). Category 4: 1.8/2 (D068 compliant, missing assumption checks). Category 5: 0.8/1 (5 concerns: power analysis critical gap)."